Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Inwards

Showing results (191-200 of 382) with videos related to

Pageof 39
Sort By:
Bone Marrow Transplantation|August 5, 2000
Delayed stem cell transplantation for the management of relapsed or refractory multiple myelomaM A Gertz, M Q Lacy, D J Inwards, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 2, 2018
Phase I trial of rituximab, cladribine, and temsirolimus (RCT) for initial therapy of mantle cell lymphomaD J Inwards, P A Fishkin, B R LaPlant, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 25, 2014
Phase I trial of rituximab, cladribine, and temsirolimus (RCT) for initial therapy of mantle cell lymphomaD J Inwards, P A Fishkin, B R LaPlant, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 11, 2008
Early lymphocyte recovery predicts superior survival after autologous stem cell transplantation in non-Hodgkin lymphoma: a prospective studyLuis F Porrata, David J Inwards, Stephen M Ansell, et al.
Orthopedics|January 9, 2010
Pathologic correlation of posterior ligamentous injury with MRIMark B Dekutoski, Meredith L Hayes, Andrew P Utter, et al.
British Journal of Haematology|May 18, 2006
Timing of autologous stem cell transplantation from last chemotherapy affects lymphocyte collection and survival in non-Hodgkin lymphomaShernan G Holtan, Luis F Porrata, David J Inwards, et al.
The Lancet. Haematology|July 5, 2016
Everolimus combined with R-CHOP-21 for new, untreated, diffuse large B-cell lymphoma (NCCTG 1085 [Alliance]): safety and efficacy results of a phase 1 and feasibility trialPatrick B Johnston, Betsy LaPlant, Ellen McPhail, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 19, 2008
Phase I clinical study of atacicept in patients with relapsed and refractory B-cell non-Hodgkin's lymphomaStephen M Ansell, Thomas E Witzig, David J Inwards, et al.
Clinical Lymphoma & Myeloma|February 28, 2007
AMD3100 affects autograft lymphocyte collection and progression-free survival after autologous stem cell transplantation in non-Hodgkin lymphomaShernan G Holtan, Luis F Porrata, Ivana N M Micallef, et al.
The Journal of Bone and Joint Surgery. American Volume|September 21, 2012
Utility of intraoperative frozen section histopathology in the diagnosis of periprosthetic joint infection: a systematic review and meta-analysisGeoffrey Tsaras, Awele Maduka-Ezeh, Carrie Y Inwards, et al.
Pageof 39

Showing results (191-200 of 382) with videos related to

Sort By:
Pageof 39
Bone Marrow Transplantation|August 5, 2000
Delayed stem cell transplantation for the management of relapsed or refractory multiple myelomaM A Gertz, M Q Lacy, D J Inwards, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 2, 2018
Phase I trial of rituximab, cladribine, and temsirolimus (RCT) for initial therapy of mantle cell lymphomaD J Inwards, P A Fishkin, B R LaPlant, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 25, 2014
Phase I trial of rituximab, cladribine, and temsirolimus (RCT) for initial therapy of mantle cell lymphomaD J Inwards, P A Fishkin, B R LaPlant, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 11, 2008
Early lymphocyte recovery predicts superior survival after autologous stem cell transplantation in non-Hodgkin lymphoma: a prospective studyLuis F Porrata, David J Inwards, Stephen M Ansell, et al.
Orthopedics|January 9, 2010
Pathologic correlation of posterior ligamentous injury with MRIMark B Dekutoski, Meredith L Hayes, Andrew P Utter, et al.
British Journal of Haematology|May 18, 2006
Timing of autologous stem cell transplantation from last chemotherapy affects lymphocyte collection and survival in non-Hodgkin lymphomaShernan G Holtan, Luis F Porrata, David J Inwards, et al.
The Lancet. Haematology|July 5, 2016
Everolimus combined with R-CHOP-21 for new, untreated, diffuse large B-cell lymphoma (NCCTG 1085 [Alliance]): safety and efficacy results of a phase 1 and feasibility trialPatrick B Johnston, Betsy LaPlant, Ellen McPhail, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 19, 2008
Phase I clinical study of atacicept in patients with relapsed and refractory B-cell non-Hodgkin's lymphomaStephen M Ansell, Thomas E Witzig, David J Inwards, et al.
Clinical Lymphoma & Myeloma|February 28, 2007
AMD3100 affects autograft lymphocyte collection and progression-free survival after autologous stem cell transplantation in non-Hodgkin lymphomaShernan G Holtan, Luis F Porrata, Ivana N M Micallef, et al.
The Journal of Bone and Joint Surgery. American Volume|September 21, 2012
Utility of intraoperative frozen section histopathology in the diagnosis of periprosthetic joint infection: a systematic review and meta-analysisGeoffrey Tsaras, Awele Maduka-Ezeh, Carrie Y Inwards, et al.
Pageof 39